Eric M Dube Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 12 hours ago
Eric M Dube has an estimated net worth of at least $75.6 million*, as of Oct. 7, 2026. They own 541,379 shares of TVTX stock. They have sold 1.1 million shares of TVTX stock since 2021, for an estimated $45.5 million.
Eric M Dube $TVTX SEC Form 4 Insider Trading
Eric M Dube has filed a total of 42 insider trades in $TVTX since 2021. Their most recent trade was a sale of 63,498 shares, made on Sep 15, 2026. Their largest trade was a sale of 101,691 shares, made on Sep 17, 2026. We estimate that they now own 541,379 shares of $TVTX, worth an estimated $30.1 million.
Insider Trading at $TVTX
There have been a total of 261 insider trades reported at $TVTX since 2021, with 0 shares purchased and 2.8 million shares sold. The most active insider traders in $TVTX stock have been Eric M Dube, Christopher R. Cline, and Elizabeth E Reed. The most recent trade was a sale of 47,746 shares reported by WILLIAM E. ROTE (Chief Research Officer), made on Sep 16, 2026.
History of Insider Stock Trades by Eric M Dube
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TVTX
|
Sale | 63,498 | Sep 15, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 6,802 | Sep 17, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 101,691 | Sep 17, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 96,125 | Sep 16, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 99,716 | Sep 16, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 270 | Sep 15, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 3,102 | Sep 15, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 28,796 | Sep 15, 2026 | Sept. 17, 2026, 9:31 p.m. |
TVTX
|
Sale | 22,500 | May 06, 2026 | May 6, 2026, 8 p.m. |
TVTX
|
Sale | 7,165 | Apr 15, 2026 | April 15, 2026, 9:48 p.m. |
TVTX
|
Sale | 20 | Apr 15, 2026 | April 15, 2026, 9:48 p.m. |
TVTX
|
Sale | 56,815 | Apr 15, 2026 | April 15, 2026, 9:48 p.m. |
TVTX
|
Sale | 25,098 | Apr 01, 2026 | April 2, 2026, 5:55 p.m. |
TVTX
|
Sale | 34,902 | Apr 01, 2026 | April 2, 2026, 5:55 p.m. |
TVTX
|
Sale | 60,000 | Feb 20, 2026 | Feb. 24, 2026, 5:05 p.m. |
TVTX
|
Sale | 33,635 | Feb 03, 2026 | Feb. 3, 2026, 10:30 p.m. |
TVTX
|
Sale | 66,452 | Feb 03, 2026 | Feb. 3, 2026, 10:30 p.m. |
TVTX
|
Sale | 51,865 | Jan 27, 2026 | Jan. 27, 2026, 9:25 p.m. |
TVTX
|
Sale | 8,135 | Jan 23, 2026 | Jan. 27, 2026, 9:25 p.m. |
TVTX
|
Sale | 27,128 | Oct 29, 2025 | Oct. 30, 2025, 4:45 p.m. |
TVTX
|
Sale | 92,872 | Oct 28, 2025 | Oct. 30, 2025, 4:45 p.m. |
TVTX
|
Sale | 18,924 | May 05, 2025 | May 5, 2025, 9:53 p.m. |
TVTX
|
Sale | 11,375 | Feb 11, 2025 | Feb. 12, 2025, 10:23 p.m. |
TVTX
|
Sale | 50,691 | Feb 03, 2025 | Feb. 4, 2025, 9:30 p.m. |
TVTX
|
Sale | 10,736 | Jan 22, 2025 | Jan. 23, 2025, 9:39 p.m. |
TVTX
|
Sale | 21,125 | Sep 09, 2024 | Sept. 9, 2024, 9:20 p.m. |
TVTX
|
Sale | 10,016 | Feb 01, 2024 | Feb. 2, 2024, 5:06 p.m. |
TVTX
|
Sale | 9,106 | Feb 01, 2024 | Feb. 2, 2024, 5:06 p.m. |
TVTX
|
Sale | 7,873 | Jan 23, 2024 | Jan. 25, 2024, 5:10 p.m. |
TVTX
|
Sale | 4,455 | Sep 05, 2023 | Sept. 5, 2023, 8:10 p.m. |
TVTX
|
Sale | 8,196 | Feb 01, 2023 | Feb. 2, 2023, 7:58 p.m. |
TVTX
|
Sale | 6,442 | Jan 24, 2023 | Jan. 26, 2023, 5:05 p.m. |
TVTX
|
Sale | 5,625 | Jan 05, 2023 | Jan. 6, 2023, 5:05 p.m. |
TVTX
|
Sale | 4,832 | Feb 10, 2022 | Feb. 11, 2022, 5:05 p.m. |
TVTX
|
Sale | 4,813 | Jan 31, 2022 | Feb. 1, 2022, 8 p.m. |
TVTX
|
Sale | 7,873 | Jan 24, 2022 | Jan. 26, 2022, 5:33 p.m. |
TVTX
|
Sale | 2,139 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
TVTX
|
Sale | 10,361 | Jan 05, 2022 | Jan. 5, 2022, 8 p.m. |
TVTX
|
Sale | 4,832 | Jan 04, 2022 | Jan. 5, 2022, 8 p.m. |
TVTX
|
Sale | 7,836 | Aug 17, 2021 | Aug. 16, 2021, 8 p.m. |
TVTX
|
Sale | 4,780 | Jun 02, 2021 | June 2, 2021, 8 p.m. |
TVTX
|
Sale | 4,782 | Jun 01, 2021 | June 2, 2021, 8 p.m. |
$TVTX Executives and Stock Owners with Insider Trades
-
Eric M Dube, CHIEF EXECUTIVE OFFICER
-
Christopher R. Cline, CHIEF FINANCIAL OFFICER
-
Elizabeth E Reed, Chief Legal Officer and GC
-
Jula Inrig, CHIEF MEDICAL OFFICER
-
Sandra Calvin, SVP, CHIEF ACCOUNTING OFFICER
-
Peter Heerma, CHIEF COMMERCIAL OFFICER
-
Eric M Dube, Chief Executive Officer
-
William E. Rote, Chief Research Officer
-
William E. Rote, Senior Vice President, R&D
-
Elizabeth E Reed, SVP, GC & Corporate Secretary
-
Sandra Calvin, SVP, Chief Accounting Officer
-
Peter Heerma, Chief Commercial Officer
-
Peter Heerma, EVP, CHIEF COMMERCIAL OFFICER
-
Elizabeth E Reed, SVP, GC & CORPORATE SECRETARY
-
William E. Rote, SENIOR VICE PRESIDENT, R&D
-
Laura Clague, Chief Financial Officer
-
Christopher R. Cline, Chief Financial Officer
-
Jula Inrig, EVP, Head of R&D & CMO
-
Jula Inrig, Chief Medical Officer
-
Noah L. Rosenberg, Chief Medical Officer
-
Sandra Calvin, VP, Corp Controller and CAO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.